AKLI:NSD-Akili Inc (USD)

COMMON STOCK | Health Information Services | NSD

Last Closing Price

USD 2.47

Change

+0.07 (+2.92)%

Market Cap

USD 0.19B

Volume

0.16M

Avg Analyst Target

N/A

Avg User Target

USD
Average Analyst Rating

Verdict

Fundamental Analysis

Verdict


AKLI Stock Forecast & Price:
Based on the Akili Inc stock forecasts from 1 analysts, the average analyst target price for Akili Inc is USD 0.00 over the next 12 months. Akili Inc’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Akili Inc is Very Bearish, which is based on 0 positive signals and 3 negative signals. At the last closing, Akili Inc’s stock price was USD 2.47. Akili Inc’s stock price has changed by -1.59% over the past week, -41.88% over the past month and 0% over the last year.

No recent analyst target price found for Akili Inc
No recent average analyst rating found for Akili Inc

About Akili Inc (AKLI:NSD)

Akili, Inc., a digital medicine company, develops digital therapeutics for cognitive impairments. It provides EndeavorRx, a physician-prescribed video game-based treatment designed to directly target cognitive functioning. The company is based in Boston, Massachusetts. Address: 1 ...Read More

Technical Indicators

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2022-10-04 )

Largest Industry Peers for Health Information Services

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
CHNG Change Healthcare Inc

N/A

USD9.03B N/A 16.98
RCM R1 RCM Inc

+0.33 (+1.75%)

USD7.75B 56.15 55.26
INOV Inovalon Holdings Inc

N/A

USD6.37B 122.57 33.93
HQY HealthEquity Inc

-0.42 (-0.62%)

USD5.63B 789.30 57.87
PINC Premier Inc

+0.54 (+1.57%)

USD4.07B 15.72 9.44
OMCL Omnicell Inc

-0.33 (-0.37%)

USD3.99B 72.60 27.65
PRVA Privia Health Group Inc

+0.87 (+2.51%)

USD3.79B N/A -78.19
PGNY Progyny Inc

+2.38 (+6.28%)

USD3.41B 88.24 181.33
ONEM 1Life Healthcare Inc

-0.11 (-0.64%)

USD3.36B N/A -12.93
HMSY HMS Holdings Corp

N/A

USD3.29B 47.40 23.59

ETFs Containing AKLI

Symbol Name Weight Mer Price(Change) Market Cap

N/A

Market Performance

  Market Performance vs.
Industry/Classification (Health Information Services)
Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Trailing 12 Months  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) N/A N/A N/A N/A N/A
Risk Adjusted Return N/A N/A N/A N/A N/A
Market Capitalization 0.19B 42% F 43% F
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 87%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Key Financial Ratios

  Ratio vs. Industry/Classification
(Health Information Services)
Ratio vs. Market
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio N/A N/A N/A N/A N/A
Price/Book Ratio N/A N/A N/A N/A N/A
Price / Cash Flow Ratio -3.58 69% D+ 60% D-
EV/EBITDA -7.20 77% C+ 79% C+
Management Effectiveness  
Return on Equity N/A N/A N/A N/A N/A
Return on Invested Capital N/A N/A N/A N/A N/A
Return on Assets N/A N/A N/A N/A N/A
Debt to Equity Ratio N/A N/A N/A N/A N/A
Technical Ratios  
Dividend Yield N/A N/A N/A N/A N/A
Short Ratio 0.02 98% A+ 98% A+
Short Percent N/A N/A N/A N/A N/A
Beta N/A N/A N/A N/A N/A
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Ratings

Target Price Action Rating Action Analyst Rating Price Date

Discussions

User / Independent Analyst Ratings

User Name Target Rating Target Horizon (Months) Target Price User Analysis Date Comment

Fundamental Analysis Breakdown

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.

Negative cashflow

The company had negative total cash flow in the most recent four quarters.

Negative free cash flow

The company had negative total free cash flow in the most recent four quarters.